Skip to content
OpenCapital
Get started

Dogwood Therapeutics DWTX Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Bioventus logo
BioventusBVS
$6.93M-30.3%
LON
LeonaBio, Inc. Common StockLONA
$691K-38.2%
PTH
Pelthos Therapeutics Inc.PTHS
$3.29M—

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0×0.0×
Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's operating lease liabilities (total)?
Dogwood Therapeutics (DWTX) reported operating lease liabilities (total) of $144.93K in Q1 2026.
How has Dogwood Therapeutics's operating lease liabilities (total) changed year-over-year?
Dogwood Therapeutics's operating lease liabilities (total) decreased by 24.2% year-over-year, from $191.24K to $144.93K.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.